Tag: VBL Therapeutics


VBL Therapeutics (NASDAQ: VBLT) Has an Update on the OVAL Phase 3 Study of VB-111 in Ovarian Cancer to be announced at the 2021 ASCO Annual Meeting

Ovarian cancer, which affects the female reproductive system, has been such a monster over the last decades. And more often than not, it goes undetected until it has ambushed the pelvis and abdomen. However, according to VBL Therapeutics (NASDAQ: VBLT), there is some hope of managing it before it early […]